The study reported reduced tumor growth with gemcitabine alone or in combination with a CXCR4 antagonist (AMD3100) or hedgehog inhibitor (GDC-0449) in orthotopic pancreatic tumor-bearing mice. Here, CXCR4 is linked to neoplasm.